Thursday - January 15, 2026
FDA Issues Warning Letter to LXR Biotech
January 14, 2026
WASHINGTON, Jan. 14 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to LXR Biotech LLC from the Human Foods Program:

* * *

Recipient: Mr. Anthony G. Orzechowski, Vice President and Chief Operating Officer, LXR Biotech, LLC, 2983 Waterview Dr., Rochester Hills, MI 48309-4600, United States, Tonyo@lxrbiotech.com

Issuing Office: Human Foods Program, United States

WARNING LETTER< . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products